Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome

American Journal of Veterinary Research

Volumn 66, Issue 2, 2005, Pages 284-288

  Erkert, Ronald S ^a   MacAllister, Charles G ^a   Payton, Mark E ^b   Clarke, Cyril R ^a  

^a 301 MSCS   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUNIXIN MEGLUMINE; PHENYLBUTAZONE; SODIUM CHLORIDE;

ANALGESIC ACTIVITY; ANALYSIS OF VARIANCE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL LAMENESS; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FORCE; HORSE DISEASE; MUSCULOSKELETAL DISEASE; NAVICULAR SYNDROME; NONHUMAN; SCORING SYSTEM; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLONIXIN; FOOT DISEASES; HORSE DISEASES; HORSES; INJECTIONS, INTRAVENOUS; LAMENESS, ANIMAL; PHENYLBUTAZONE; SYNDROME; TREATMENT OUTCOME;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 12744258546     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.284     Document Type: Article

References (35)

1. McIlwraith CW, Frisbie DD, Kawcak CE. Nonsteroidal anti-inflammatory drugs, in Proceedings. 47th Annu Meet Am Assoc Equine Pract 2001;182-187.
2. Lees P, Higgins AJ. Clinical pharmacology and therapeutic uses of non-steroidal anti-inflammatory drugs in the horse. Equine Vet J 1985;17:83-96.
3. Chay S, Woods WE, Nugent T, et al. The pharmacology of nonsteroidal anti-inflammatory drugs in the horse: flunixin meglumine (Banamine). Equine Pract 1982;4:16-23.
4. Gaughan EM. The use of NSAIDs in treating equine joint disease. Equine Med Rev 2002;12:1-4.
5. McIlwraith CW. Medications for joint disease: nonsteroidal anti-inflammatory drugs. In: Stashak TS, ed. Adams' lameness in horses 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2002; 494-498.
6. Kallings P. Nonsteroidal anti-inflammatory drugs. Vet Clin North Am Equine Pract 1993;9:523-562.
7. Stashak TS. Navicular syndrome (navicular disease or navicular region pain). In: Stashak TS, ed. Adams' lameness in horses 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2002; 664-680.
8. Higgins AJ, Lees P, Taylor JB. Influence of phenylbutazone on eicosanoid levels in equine acute inflammatory exudates. Cornell Vet 1984;74:198-207.
9. Johnston SA, Fox SM. Mechanisms of action of anti-inflammatory medications used for the treatment of osteoarthritis. J Am Vet Med Assoc 1997;210:1486-1492.
10. Toutain PL, Autefage A, Legrand C, et al. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modeling. J Vet Pharmacol Ther 1994;17:459-469.
11. Hu HH, MacAllister CG, Payton ME, et al. Evaluation of the analgesic effects of phenylbutazone administered at high or low dosage in horses with chronic lameness. J Am Vet Med Assoc 2005;226:414-417.
12. Higgins AJ, Lees P, Taylor JBO, et al. Flunixin meglumine: quantitative determination in and effects on composition of equine inflammatory exudate. Br Vet J 1986;142:163-169.
13. Ackerman N, Johnson JH, Dorn CR. Navicular disease in the horse: risk factors, radiographic changes, and response to therapy. J Am Vet Med Assoc 1977;170:183-187.
14. Lowe JE. Sex, breed and age incidence of navicular disease, in Proceedings. 20th Annu Meet Am Assoc Equine Pract 1976;37.
15. Stashak T. Navicular syndrome (navicular disease). In: White NA, Moore JN, eds. Current techniques in equine surgery and lameness 2nd ed. Philadelphia: WB Saunders Co, 1998;537-544.
16. Turner TA. Diagnosis and treatment of navicular disease in horses. Vet Clin North Am Equine Pract 1989;5:131-143.
17. Page BT, Hagen TL. Breakover of the hoof and its effect on structures and forces within the foot. J Equine Vet Sci 2002;22:258-264.
18. Pool RR, Meagher DM, Stover SM. Pathophysiology of navicular disease. Vet Clin North Am Equine Pract 1989;5:109-129.
19. Svalastoga E, Smith M. Navicular disease in the horse: the subchondral bone pressure. Nord Vet Med 1983;35:31-37.
20. Leach DH. Treatment and pathogenesis of navicular disease ("syndrome") in horses. Equine Vet J 1993;25:477-481.
21. Barr ARS, Dow SM, Goodship AE. Parameters of forelimb ground reaction force in 48 normal ponies. Vet Rec 1995;136:283-286.
22. Schamhardt HC, Merkens HW. Quantification of equine ground reaction force patterns. J Biomech 1987;20:443-446.
23. McLaughlin RM, Gaughan EM, Roush JK, et al. Effects of subject velocity on ground reaction force measurements and stance times in clinically normal horses at the walk and trot. Am J Vet Res 1996;57:7-11.
24. Merkens HW, Schamhardt HC. Evaluation of equine locomotion during different degrees of experimentally induced lameness. I: Lameness model and quantification of ground reaction force patterns of the limbs. Equine Vet J Suppl 1988;6:99-106.
25. Merkens HW, Schamhardt HC. Evaluation of equine locomotion during different degrees of experimentally induced lameness. II: Distribution of ground reaction force patterns of the concurrently loaded limbs. Equine Vet J Suppl 1988;6:107-112.
26. Merkens HW, Schamhardt HC, van Osch GJ, et al. Ground reaction force patterns of Dutch Warmblood horses at normal trot. Equine Vet J 1993;25:134-137.
27. Merkens HW, Schamhardt HC, van Osch GJ, et al. Ground reaction force patterns of Dutch Warmbloods at the canter. Am J Vet Res 1993;54:670-674.
28. Keegan KG, Wilson DA, Wilson DJ, et al. Evaluation of mild lameness in horses trotting on a treadmill by clinicians and interns or residents and correlation of their assessments with kinematic gait analysis. Am J Vet Res 1998;59:1370-1377.
29. American Association of Equine Practitioners (AAEP). Lameness scale. Definition and classification of lameness. In: Guide for veterinary service and judging of equestrian events. 4th ed. Lexington, Ky: American Association of Equine Practitioners, 1991;19.
30. MacAllister CG. Force plate analysis for the evaluation of NSAIDs in chronically lame horses, in Proceedings. 21st Forum Am Coll Vet Med 2003;162-163.
31. Morris EA, Seeherman HJ. Redistribution of ground reaction forces in experimentally induced equine carpal lameness. Equine Exerc Physiol 1987;2:553-563.
32. Lees P, Taylor JB, Maitho TE, et al. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse. Cornell Vet 1987;77:192-211.
33. Soma LR, Behrend E, Rudy J, et al. Disposition and excretion of flunixin meglumine in horses. Am J Vet Res 1988;49:1894-1898.
34. 2 production in equine inflammation. Res Vet Sci 1984;37:347-349.
35. Lees P, Taylor JBO, Higgins AJ, et al. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse. J Vet Pharmacol Ther 1986;9:204-212.